Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hyaluronidase refers to a family of enzymes that catalyze the degradation of hyaluronic acid, a major component of the extracellular matrix. By breaking down hyaluronic acid, these enzymes reduce the viscosity of extracellular fluids and increase tissue permeability. Different isoforms (HYAL1-5) exist with distinct tissue distributions and functions, including roles in drug absorption, fertilization, and cancer progression. Marketed forms include recombinant human hyaluronidase used for improving drug dispersion during injections or managing complications from dermal fillers.
Hydrolysis of β(1→4) glycosidic bonds between N-acetylglucosamine and glucuronic acid residues in hyaluronic acid, reducing its molecular size and viscosity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyaluronidase.